Unlock instant, AI-driven research and patent intelligence for your innovation.

A new crystal form of sofosbuvir and its preparation method

A technology of sofosbuvir and Wei crystal, applied in the field of new crystal forms of sofosbuvir and its preparation, can solve problems such as being unfavorable for dry granulation operation, unfavorable for industrial application, difficult to be pressed into ribbons, etc., and achieve process stability Good, stable and controllable quality, short drying time

Active Publication Date: 2021-05-04
CSPC ZHONGQI PHARM TECH (SHIJIAZHUANG) CO LTD
View PDF18 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The preparation method takes a long time for crystallization, which is not conducive to industrial application; the material density is small, it is easy to block the feeding port, it is difficult to press into ribbons, and it is not conducive to dry granulation operation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A new crystal form of sofosbuvir and its preparation method
  • A new crystal form of sofosbuvir and its preparation method
  • A new crystal form of sofosbuvir and its preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Embodiment 1: Preparation of sofosbuvir β crystal form

[0045] Put 100g of sofosbuvir form 1 into 200ml of acetone, heat to 35-45°C, slowly add 400ml of isopropyl ether within 5 minutes, add 200ml of isopropyl ether after stirring for 0.5 hours, and cool the mixture to 5-10°C in an ice-water bath After continuing to stir for 1 hour, filter, wash the filter cake with isopropyl ether, and vacuum-dry at 35-50°C for 4-5 hours to obtain sofosbuvir β crystal form, weight 90g, yield 90%. figure 1 , and its X-ray diffraction data are shown in Table 1:

[0046] Sofosbuvir β crystal form X-ray diffraction data of Table 1 Example 1

[0047]

[0048]

Embodiment 2

[0049] Embodiment 2: Preparation of sofosbuvir β crystal form

[0050] Put 112g of sofosbuvir form 1 into 600ml of isopropanol, heat to 25-40°C, add about 0.6g of sofosbuvir β crystal form prepared in Example 1 under stirring as a seed crystal, and continue stirring for 0.5 hours Slowly add 600ml of n-heptane, stir for 1 hour, continue to add 2400ml of n-heptane, continue stirring for 1 hour, filter, wash the filter cake with isopropanol:n-heptane = 1:5, and vacuum dry at 35-50°C for 7-8 Sofosbuvir β crystal form was obtained in 1 hour, weight 102g, yield 91%, and its X-ray diffraction data are as shown in Table 2:

[0051] Sofosbuvir β crystal form X-ray diffraction data of Table 2 Example 2

[0052] 2θ(°) Relative Strength(%) 8.046 100.0 10.338 37.4 12.371 75.2 13.432 15.8 16.172 10.7 16.762 26.3 17.162 13.9 18.653 10.0 19.346 37.1 19.953 29.9 20.785 29.3

Embodiment 3

[0053] Embodiment 3: Preparation of sofosbuvir β crystal form

[0054] Put 164g of sofosbuvir form 1 into 410ml of ethanol, heat to 25-40°C, stir for 1 hour, then slowly add 410ml of n-heptane, keep stirring at the temperature until the system is viscous, continue to add 1640ml of n-heptane, and continue stirring after adding After filtering for 1 hour, the filter cake was washed with ethanol:n-heptane = 1:2, and vacuum-dried at 35-50°C for 7-8 hours to obtain sofosbuvir β-crystal form, weighing 154g, yield 94%. , and its X-ray diffraction data are shown in Table 2:

[0055] Sofosbuvir β crystal form X-ray diffraction data of Table 3 Example 3

[0056] 2θ(°) Relative Strength(%) 8.160 100.0 10.438 47.7 12.457 70.1 13.531 15.3 16.255 11.0 16.927 17.2 17.245 27.0 18.755 14.5 19.443 55.7 20.077 43.5 20.869 41.0

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
angle of reposeaaaaaaaaaa
Login to View More

Abstract

The invention discloses a new crystal form of sofosbuvir and a preparation method thereof. The powder X-ray diffraction of the new crystal form of sofosbuvir of the present invention is 8.1±0.2°, 10.4±0.2°, 12.4±0.2°, 16.9±0.2°, 17.2±0.2°, 19.4±0.2°, 20.1±0.2° at 2θ °, there are characteristic peaks at 20.9±0.2°. The new sofosbuvir crystal form of the present invention has high bulk density, good fluidity, is more conducive to dry granulation operation, avoids the crystallization process in the aqueous system, has mild preparation process conditions, low energy consumption, simple operation, and no sticky jelly and Agglomeration occurs, the reaction kettle is not blocked, the quality is stable and controllable, the process cost is low, and it is suitable for industrial production, which provides a new way for the preparation of sofosvir medicine.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a new crystal form of sofosbuvir and a preparation method thereof. Background technique [0002] Hepatitis C is a viral hepatitis caused by hepatitis C virus (HCV) infection, which can lead to chronic inflammation, necrosis and fibrosis of the liver, and some patients can develop liver cirrhosis or even hepatocellular carcinoma (HCC). extremely harmful to health and life. [0003] Hepatitis C is a global epidemic. According to the statistics of the World Health Organization, there are more than 200 million infected people in the world, and there are at least 3 to 4 million newly infected people every year. The current treatment for hepatitis C is mainly immunotherapy with recombinant interferon-beta alone or combined with nucleoside analogue ribavirin, and the clinical effect is limited. [0004] Sofosbuvir (Sofosbuvir), is a new drug developed by Gilead Pharmaceut...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07H19/10C07H1/06
CPCC07B2200/13C07H1/06C07H19/10
Inventor 李志怀郝红茹梁鑫磊道硕金晓利刘春玲曹泽峰潘登马玉秀
Owner CSPC ZHONGQI PHARM TECH (SHIJIAZHUANG) CO LTD